Assignee
VYRIPHARM ENTPR INC
US·1 granted patent·4 pending applications·0 citations·filing 2022–2022
Top patents by PatentIndex Score
5 records- 0158US11554184B2Synthetic cannabinoid combination therapy compositions and methods for personalized and targeted therapies including the treatment of infectious diseasesVYRIPHARM ENTPR INC·Filed 2022·Granted Jan 17, 2023·0 cites·6 claims
- 0250US2022370650A1Formulations and kits for the diagnostic evaluation of infectious diseases and methods thereofVYRIPHARM ENTPR INC·Filed 2022·Application pending·0 cites
- 0350US2022305148A1Natural cannabinoid combination therapy compositions and methods for personalized and targeted therapies including the treatment of infectious diseasesVYRIPHARM ENTPR INC·Filed 2022·Application pending·0 cites
- 0450US2022305145A1Compositions and methods for diagnosing viral infections including covid-19 and for infection severity monitoring as well as targeted detection of cytokine stormVYRIPHARM ENTPR INC·Filed 2022·Application pending·0 cites
- 0541US2022305146A1Radiopharmaceutical compositions and methods for infectious disease diagnosis and therapyVYRIPHARM ENTPR INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →